Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CareDx, Inc. - Common Stock
(NQ:
CDNA
)
20.04
-0.53 (-2.58%)
Streaming Delayed Price
Updated: 12:56 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CareDx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
January 12, 2026
From
CareDx, Inc.
Via
Business Wire
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
January 07, 2026
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 26, 2025
From
CareDx, Inc.
Via
Business Wire
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
4 Analysts Assess CareDx: What You Need To Know
↗
September 23, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
CareDx Provides Notice of Proposed Derivative Settlement
December 18, 2025
From
CareDx, Inc.
Via
Business Wire
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
November 24, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in Upcoming Investor Conferences
November 10, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 07, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
November 06, 2025
From
CareDx, Inc.
Via
Business Wire
3 Analysts Have This To Say About CareDx
↗
November 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 05, 2025
Via
Benzinga
What's going on in today's after hours session
↗
November 04, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
CareDx Announces Third Quarter 2025 Financial Results
November 04, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
October 27, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
October 23, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
October 22, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
October 21, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
October 06, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Issues Comment Letter on Draft LCD Policy
September 02, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential
↗
August 26, 2025
CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market.
Via
Benzinga
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
↗
August 26, 2025
Via
Benzinga
CareDx to Participate in Wells Fargo Healthcare Conference
August 21, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx (CDNA) EPS Beats Sales Gain 14%
↗
August 06, 2025
Via
The Motley Fool
CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth
↗
August 06, 2025
CareDx Inc (CDNA) reported mixed Q2 2025 results with revenue of $86.7M, missing estimates, but adjusted revenue rose 14% YoY. Testing volumes grew 13%, while shares fell 6.8% post-earnings.
Via
Chartmill
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
August 06, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Second Quarter 2025 Financial Results
August 06, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation
August 06, 2025
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress
July 31, 2025
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
